Pre-treatment with potent P2Y12 receptor inhibitors is associated with reduced in-hospital mortality in a real world setting of primary percutaneous coronary intervention
28 August 2016 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
National Hospital Klagenfurt, Klagenfurt (Austria)
24 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
08:30 CET
